Please Wait...

Pathway to Quality Cardiovascular Imaging Trials

Cardiovascular diseases are the leading cause of death in the world and as such, the cause, prevention and treatment of all cardiovascular disease remains a very active field in the research community. Cardiovascular Imaging is a primary therapeutic service area for Bioclinica, offering comprehensive centralized medical imaging services and support for the majority of all cardiovascular imaging (CVI) modalities leveraged to provide critical endpoint assessments in clinical research.

The corner stone to our service is Quality. There are many facets to incorporating imaging into a research protocol and is a road traveled for many years at Bioclinica. Our experience covers imaging modalities across a broad range of cardiovascular and non-cardiovascular therapeutics and devices. We have the physician expertise readily available to provide current clinical knowledge to deploy imaging strategies most appropriate for the study endpoints.

There is much more to imaging in clinical research than collecting scans and analyzing them. It includes many components for a successful outcome of quality data. A thoughtful and comprehensive imaging protocol, training across the study team, and an imaging charter with the appropriate analysis parameters are just some of the critical stops on the road to quality and timely delivery of imaging data.

Our experience covers many of the key cardiovascular disease states that inflict patients today such as heart failure, atherosclerosis, hypertension, valvular disease, cardiomyopathies and vascular disease. Published imaging guidelines and documented standard procedures are applied to trials investigating new treatments for these conditions across all CVI modalities for the consistent collection and processing of data to ensure integrity for your trial. Additionally, many non-cardiovascular diseases such as cancer, rheumatoid arthritis and muscular dystrophy leverage cardiovascular imaging to assess safety in the development of new therapies.

With 30+ years of experience in the conduct of imaging clinical trials, Bioclinica offers in-house expertise as well as a network of academic and research Key Opinion Leaders (KOLs) who readily conduct image review, quality assessment and imaging charter support. Our KOLs are well recognized for their cardiovascular expertise and act as additional resources as you plan your cardiovascular drug programs.

If you'd like to learn more about Bioclinica's Cardiovascular Imaging services, please download our data sheet. If you are attending ACC 2017 in Washington, DC, March 17-19, 2017, we welcome a chance to connect. Email me to pre-arrange a one-to-one meeting.

Category: 

Meet with us!

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @Xtalks: Removing Risk from #ClinicalTrial Management System (CTMS) Implementations @bioclinica https://t.co/EfuSVMSL13
bioclinica (2 hours ago)
Our Research Dev. Director Marieke Cajal in a poster presentation at #CNS Summit showed, "How to Scale up Recruitme… https://t.co/ySQpGIjvt9
bioclinica (2 hours ago)
Great advice on imaging in #clinicaltrials! https://t.co/adsP8h99Ic
bioclinica (3 days ago)
https://t.co/UZQTot9ovJ
bioclinica (3 days ago)
RT @Xtalks: When is Central Imaging Needed in #ClinicalTrials? @bioclinica https://t.co/fYGvqU46TI
bioclinica (3 days ago)
RT @phillytechnews: 11/7: BioClinica, USA Technologies buy California firms ; First Round names female general partner https://t.co/MAvm6…
bioclinica (3 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices